4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-24-002804
Options or other derivatives
- CSO & EVP Clinical Development acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Stark Charles William CSO & EVP Clinical Development | 2024-02-01 | Grant or award · Options | +200,000 | $0.15 | $30,000 | 200,000 | D |
Loading xslF345X05/doc4.xml…